Miyake, M.; Hori, S.; Owari, T.; Oda, Y.; Tatsumi, Y.; Nakai, Y.; Fujii, T.; Fujimoto, K.
Clinical Impact of Tumor-Infiltrating Lymphocytes and PD-L1-Positive Cells as Prognostic and Predictive Biomarkers in Urological Malignancies and Retroperitoneal Sarcoma. Cancers 2020, 12, 3153.
https://doi.org/10.3390/cancers12113153
AMA Style
Miyake M, Hori S, Owari T, Oda Y, Tatsumi Y, Nakai Y, Fujii T, Fujimoto K.
Clinical Impact of Tumor-Infiltrating Lymphocytes and PD-L1-Positive Cells as Prognostic and Predictive Biomarkers in Urological Malignancies and Retroperitoneal Sarcoma. Cancers. 2020; 12(11):3153.
https://doi.org/10.3390/cancers12113153
Chicago/Turabian Style
Miyake, Makito, Shunta Hori, Takuya Owari, Yuki Oda, Yoshihiro Tatsumi, Yasushi Nakai, Tomomi Fujii, and Kiyohide Fujimoto.
2020. "Clinical Impact of Tumor-Infiltrating Lymphocytes and PD-L1-Positive Cells as Prognostic and Predictive Biomarkers in Urological Malignancies and Retroperitoneal Sarcoma" Cancers 12, no. 11: 3153.
https://doi.org/10.3390/cancers12113153
APA Style
Miyake, M., Hori, S., Owari, T., Oda, Y., Tatsumi, Y., Nakai, Y., Fujii, T., & Fujimoto, K.
(2020). Clinical Impact of Tumor-Infiltrating Lymphocytes and PD-L1-Positive Cells as Prognostic and Predictive Biomarkers in Urological Malignancies and Retroperitoneal Sarcoma. Cancers, 12(11), 3153.
https://doi.org/10.3390/cancers12113153